| Aldara Information from Drugs.com Aldara (imiquimod) is used to treat actinic keratosis, basal cell carcinoma and genital warts. Includes Aldara side effects, interactions and indications. Read More |
| Aldara Official FDA information, side effects and uses. Accurate, FDA approved Aldara information for healthcare professionals and patients - brought to you by Drugs.com. Read More |
| Aldara Cream Some people have had serious Aldara side effects. Read about their symptoms after using Aldara. Know the Aldara risks before you use it. Read More |
| Aldara (Imiquimod) Drug Information: Description, User Reviews ... Learn about the prescription medication Aldara (Imiquimod), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Read More |
| Aldara Top : Uses, Side Effects, Interactions, Pictures, Warnings ... Find patient medical information for Aldara Top on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Read More |
| European Medicines Agency - Find medicine - Aldara This is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies ... Read More |
| Aldara - Cyberchemist homepage Aldara ™ Imiquimod Cream 5% What is in this Leaflet. This leaflet answers some common questions about Aldara. It does not contain all the available information. Read More |
| Imiquimod - Wikipedia, the free encyclopedia It is marketed by Meda AB, Graceway Pharmaceuticals and iNova Pharmaceuticals under the trade names Aldara and Zyclara, and by Mochida as Beselna. Read More |
| Aldara - Your Medication For Wart Treatment Is Aldara a miracle or another crappy medical? How can it help you? What are its side effects? Let's find out. Read More |
| ZYCLARA (imiquimod) Cream, 3.75% | Rx Only ZYCLARA (imiquimod) Cream 3.75% ... ZYCLARA ® Cream is a prescription medication for use on the skin (topical) to treat actinic keratosis (AK) of the full face or ... Read More |